- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
This Week in Managed Care: August 15, 2015
CVS stunned the healthcare community this week with the announcement that it will wait for the FDA to approve a second PCSK9 inhibitor before it negotiates prices and there has been renewed attention on the need for enforcement of the federal parity law for mental health.
The top story in managed care came CVS, which surprised the healthcare community when it announced it would await the approval of a second PCSK9 inhibitor before it negotiated pricing for this new class of drugs. Sanofi and Regeneron's alirocumab was approved July 24 and Amgen's evolucumab comes up for approval on August 27. The cholesterol-lowering therapy could be the most costly class of medications if it is used broadly, according to William Shrank, MD, chief scientific officer of CVS.
In recent weeks, there has been renewed attention to the need for enforcement of the federal parity law for mental health. While primary care can often be the first stop for those in need of mental health treatment, but the stigma of asking for help can prevent patients from seeking care, explained John Santopietro, MD, of the Carolinas Health System.
Finally, attend The American Journal of Managed Care's Patient-Centered Oncology Care meeting in Baltimore, November 19-20, and learn more about how FDA regulation will affect precision medicine in the future. For our agenda and registration, visit the meetings page here.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
